BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
721 results:

  • 1. Real-World Analysis of the Clinical and Economic Impact of the 21-Gene Recurrence Score (RS) in Invasive Lobular Early-Stage breast Carcinoma in Ireland.
    McSorley LM; Tharmabala M; Al Rahbi F; Keane F; Evoy D; Geraghty JG; Rothwell J; McCartan DP; Greally M; O'Connor M; O'Mahony D; Keane M; Kennedy MJ; O'Reilly S; Millen SJ; Crown JP; Kelly CM; Prichard RS; Quinn CM; Walshe JM
    Curr Oncol; 2024 Mar; 31(3):1302-1310. PubMed ID: 38534931
    [No Abstract]    [Full Text] [Related]  

  • 2. Assessment of the Surgical Oncology Case Volume Within the Public Sector in Tanzania.
    Brand NR; Akoko L; Kotecha V; Mwakyembe T; Mwashambwa M; Hamid R; Hando D; Komba C; Mwanga A; Mbele P; Itule P; Jackson J; Misidai M; Gaskill C; Ozgediz D
    JCO Glob Oncol; 2024 Mar; 10():e2300316. PubMed ID: 38452305
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cost-effectiveness analysis of add-on pertuzumab to trastuzumab biosimilar and chemotherapy as neoadjuvant treatment for human epidermal growth receptor 2-positive early breast cancer patients in Singapore.
    Lim EH; Lim A; Khara JS; Cheong J; Fong J; Sivanesan S; Griffiths M; New E; Lee SC
    Expert Rev Pharmacoecon Outcomes Res; 2024 Mar; 24(3):413-426. PubMed ID: 38289042
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ARHGAP6 Suppresses breast cancer Tumor Growth by Promoting Ferroptosis via rhoa-ROCK1-p38 MAPK Signaling.
    Chen X; Zhu J; Li X; Chen J; Zhou Z; Fan X; Liang R; Liu H; Zhu D
    Front Biosci (Landmark Ed); 2024 Jan; 29(1):6. PubMed ID: 38287795
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of breast cancer Screening Results and Influencing Factors of breast cancer in Guangdong Province from 2017 to 2021.
    Wu L; Chen GZ; Zeng ZR; Ji CW; Zhang AQ; Xia JH; Liu GC
    J Epidemiol Glob Health; 2024 Mar; 14(1):131-141. PubMed ID: 38224387
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Anticancer Effects of Marine Carotenoid Fucoxanthin through Phosphatidylinositol 3-Kinase (PI3K)-AKT Signaling on Triple-Negative breast cancer Cells.
    Ahmed SA; Mendonca P; Messeha SS; Oriaku ET; Soliman KFA
    Molecules; 2023 Dec; 29(1):. PubMed ID: 38202644
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Air quality and cancer risk in the All of Us Research Program.
    Craver A; Luo J; Kibriya MG; Randorf N; Bahl K; Connellan E; Powell J; Zakin P; Jones RR; Argos M; Ho J; Kim K; Daviglus ML; Greenland P; Ahsan H; Aschebrook-Kilfoy B
    Cancer Causes Control; 2024 May; 35(5):749-760. PubMed ID: 38145439
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice.
    Fukada I; Mori S; Hayashi N; Hosonaga M; Xiaofei W; Yamazaki M; Ueki A; Kiyotani K; Tonooka A; Takeuchi K; Ueno T; Takahashi S
    Cancer Sci; 2023 Dec; 114(12):4632-4642. PubMed ID: 37858313
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Quality indicators for the diagnosis and treatment of breast cancer integrated assistance: A critical appraisal.
    Maes-Carballo M; Martín-Díaz M; Mignini L; Khan KS; Trigueros R; Bueno-Cavanillas A
    Semergen; 2024; 50(1):102067. PubMed ID: 37827047
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MRI-based radiomic models to predict surgical margin status and infer tumor immune microenvironment in breast cancer patients with breast-conserving surgery: a multicenter validation study.
    Ma J; Chen K; Li S; Zhu L; Yu Y; Li J; Ma J; Ouyang J; Wu Z; Tan Y; He Z; Liu H; Pan Z; Li H; Liu Q; Song E
    Eur Radiol; 2024 Mar; 34(3):1774-1789. PubMed ID: 37658888
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced breast cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Blumencranz P; Habibi M; Shivers S; Acs G; Blumencranz LE; Yoder EB; van der Baan B; Menicucci AR; Dauer P; Audeh W; Cox CE
    Ann Surg Oncol; 2023 Dec; 30(13):8353-8361. PubMed ID: 37658272
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic performance of MRI for assessing axillary lymph node status after neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Li Z; Ma Q; Gao Y; Qu M; Li J; Lei J
    Eur Radiol; 2024 Feb; 34(2):930-942. PubMed ID: 37615764
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Factors Predicting Response in breast cancer Receiving Neoadjuvant Therapy and the Role of Ki67 Labeling Index.
    Ekinci F; Uzun M; Demir B; Unek IT; Erdogan AP
    J Coll Physicians Surg Pak; 2023 Aug; 33(8):872-878. PubMed ID: 37553925
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CdGAP is a talin-binding protein and a target of TGF-β signaling that promotes HER2-positive breast cancer growth and metastasis.
    He Y; Goyette MA; Chapelle J; Boufaied N; Al Rahbani J; Schonewolff M; Danek EI; Muller WJ; Labbé DP; Côté JF; Lamarche-Vane N
    Cell Rep; 2023 Aug; 42(8):112936. PubMed ID: 37552602
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Role of
    Géci I; Bober P; Filová E; Amler E; Sabo J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511111
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in cancer Cells.
    Zwergel C; Aventaggiato M; Garbo S; Di Bello E; Fassari B; Noce B; Castiello C; Lambona C; Barreca F; Rotili D; Fioravanti R; Schmalz T; Weyand M; Niedermeier A; Tripodi M; Colotti G; Steegborn C; Battistelli C; Tafani M; Valente S; Mai A
    J Med Chem; 2023 Jul; 66(14):9622-9641. PubMed ID: 37439550
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Same-Day Discharge for Immediate breast Reconstruction: A National Surgical Quality Improvement Program Study.
    Miller A; Jain NS; Wells MW; Da Lio A; Roostaeian J; Crisera C; Slack G; Tseng C; Delong M; Festekjian JH
    Plast Reconstr Surg; 2024 Apr; 153(4):683e-689e. PubMed ID: 37335577
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in breast cancer: A Two-Center study.
    Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
    Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer.
    Xiao G; Cheng F; Yuan J; Lu W; Wang P; Fan H
    Oncol Res; 2022; 30(1):35-51. PubMed ID: 37304008
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study.
    Rossi A; Aimar G; Audisio M; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Ghisoni E; Lombardi P; Marandino L; Mariniello A; Paratore C; Reale ML; Trastu F; Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M
    Eur J Cancer; 2023 Aug; 189():112920. PubMed ID: 37277262
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 37.